
==== Front
Pak J Med Sci
Pak J Med Sci
Pakistan Journal of Medical Sciences
1682-024X
1681-715X
Professional Medical Publications Pakistan

PJMS-37-393
10.12669/pjms.37.2.3614
Original Article
Frequency of intra-aortic balloon pump insertion and associated factors in coronary artery bypass Grafting in a tertiary care hospital
Ahmad Imtiaz 1
Islam Mujahid Ul 2
Rehman Mujeeb Ur 3
Khan Bahauddin 4
1 Dr. Imtiaz Ahmad, FCPS. Associate Professor, Department of Anesthesia, Northwest General Hospital and Research Center, Peshawar, Pakistan
2 Dr. Mujahid Ul Islam, FCPS. Associate Professor, Department of Anesthesia, Northwest General Hospital and Research Center, Peshawar, Pakistan
3 Dr. Mujeeb Ur Rehman, MS. Senior Medical Officer, Department of Cardiothoracic Surgery, Rehman Medical Institute, Peshawar, Pakistan
4 Dr. Bahauddin Khan, FCPS. Assistant Professor, Department of Cardiothoracic Surgery, Northwest General Hospital and Research Center, Peshawar, Pakistan
Correspondence: Dr. Mujeeb Ur Rehman, MBBS, MS. Cardiothoracic Surgery Unit-B, Rehman Medical Institute, Hayatabad, Peshawar, Pakistan. Email: wilsonrachel@example.net
Mar-Apr 2021
37 2 393397
07 9 2020
19 10 2020
04 12 2020
15 12 2020
27 12 2020
Copyright: © Pakistan Journal of Medical Sciences
2021
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Objective:

To find the incidence of intra-aortic balloon pump (IABP) induction and factors associated with its insertion in coronary artery bypass grafting (CABG).

Methods:

This retrospective observational non interventional study was conducted at Cardiac Surgery Department, North West General Hospital and Research Center, Peshawar from December 2018 to March 2020. The total sample size was 360 patients who underwent coronary artery bypass grafting (CABG). The research was piloted in the cardiac operation theatre then cardiac intensive care unit (CICU) of Northwest General Hospital and Research center Hayatabad Peshawar. Data was collected from 360 patients scheduled for CABG. Total numbers of patients in whom IABP was inserted and factors associated with IABP insertions were noted. All the information was collected on a specifically prepared Form. Data was entered and evaluated in statistical package for social sciences form 25.

Results:

In this study, a total of 360 patients were observed who underwent coronary artery bypass grafting (CABG). We determined the frequency of IABP induction and the factors related to it. Gender distribution among patients who were assisted with IABP was 43% female and 57% male. IABP induction was done for most of moderately to severely reduced ejection fraction patients. Other factors related to patients who required IABP support were previous myocardial infarction 100%, hypertension 86%, diabetes mellitus 64%, coronary end-arterectomy 21% and smoking 7%. The results were analyzed. We have used the (SPSS) version 25 and Chi-square test for analysis in which the P-value less than 0.00001 is statistically significant.

Conclusion:

Incidence of insertion of IABP among CABG population was 3.9% in our hospital. It is an essential support to post CABG patient with left ventricular dysfunction after cardiopulmonary bypass with moderate to severely reduced ejection fraction, Myocardial infarction, hypertension, diabetes mellitus. Smoking and endarterectomy were not significantly related to IABP induction in our study. Multicenter study is still required to find out the other factors governing the IABP insertion.

IABP
Frequency
Cardiac Surgery
CABG
Left Ventricular Dysfunction
==== Body
Abbreviations

CABG: Coronary Artery Bypass Grafting Surgery

EF: Ejection Fraction

CAD: Coronary Artery Disease

PCI: Percutaneous Coronary Intervention

ICU: Intensive Care Unit

IABP: Intra-aortic Balloon Pump

CICU: Cardiac Intensive Care Unit

MI: Myocardial Infarction

INTRODUCTION

Coronary artery disease (CAD) has been considered the important cause of death worldwide. Modern techniques in cardiac surgery and perioperative care have drastically reduced the patient's complications in cardiac surgery but the frequency of this global disease is still high.1

Choices for management of CAD comprise medical therapies, percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). Prognosis of CAD is dependent on interventions, baseline personality and genetics.2 With the progress of coronary interventional treatment and the popularity of PCI, patients who are experiencing CABG are aged and might have more common coexisting diseases like diabetes mellitus and chronic renal failure which lead to high risk of cardiac surgery.3

For cardiac surgery risk evaluation Euro SCORE has been extensively used, which stratifies cardiac surgical risk into three categories: low-risk (0–2 points); intermediate-risk (3–5 points), and high-risk (more than or equal six points.4 These high risk patients with coronary artery disease presenting for CABG mostly have left ventricular (LV) dysfunction.5 Most of the research has revealed an encouraging survival advantage in patients undergoing surgical treatment of CAD.6,7 Nevertheless, severe LV dysfunction (ejection fraction ≤ 35%) is stated to be the predictor of low cardiac output syndrome and mortality in CABG.7,8

Regardless of recent development in treatment, the management of individuals presenting for cardiac surgery with severe left ventricular dysfunction remains a challenge so that mechanical assist devices have been developed to be used in such patients.9 One such mechanical assist devices is the intra-aortic balloon pump (IABP) passed via femoral artery that was presented for the first time in 1962 which provides circulatory support.10

The IABP is the most frequently used ventricular mechanical support gadget in recent times in patients with ventricular dysfunction making it an immensely beneficial approach in post CABG patients with moderate to severely reduced ejection fraction.11 The inflation of IABP occurs during diastole with aortic valve closure synchronously and the presence of dicrotic notch results in displacing of blood into the peripheral circulation from the thoracic aorta which is followed by fast deflation prior the onset of systole period of the cardiac cycle. So IABP can pick up diastolic perfusion pressure, coronary blood flow and myocardial oxygen delivery. It can also reduce left ventricular after load, ventricular work, oxygen expenditure, and encourage cardiac function revitalization.12

Our objective was to find the incidence of intra-aortic balloon pump (IABP) induction and factors associated with its insertion in coronary artery bypass grafting (CABG).

METHODS

This non interventional retrospective study was conducted and approved by ethical committee of Northwest General Hospital and Research Center, a tertiary care hospital located in Hayatabad, Peshawar with Ref. No.: NWGH/EC/18, August 22, 2020. The research was commenced from December 2018 till March 2020, and informed consent was obtained from all the participants. Overall 360 adult patients of both sexes scheduled for CABG surgical procedure were included in the study.

All the necessary pre-operative regular blood tests along with specific investigation for cardiac surgery were performed. Not only on-pump but also off pump cardiopulmonary bypass was performed according to patient's requirement. During bypass mild to moderate hypothermia was maintained. We used ante grade cold-blooded cardioplegia through the aortic root or the venous graft in our center.

Triggers for insertion of intra-aortic balloon pump after cardiopulmonary bypass in our setup were continuous hypotension with visible cardiac function worsening and signs of tissue hypo perfusion like cold extremities and lowered urine production in spite of elevated inotropic support and fluid boluses. The significance of this study is to keep an eye on special factors leading to IABP insertion like low ejection fraction, DM, MI, HTN.

Comprehensive statistics which include age, gender, procedure, coexisting disease, previous myocardial infarction, left ventricular function according to left ventricular ejection fraction, diseased coronary arteries, intraoperative findings and parameters of participants were documented through a precisely constructed Form afterwards analyzed by using (SPSS) version 25 and Chi-square test for analysis in which the P-value less than 0.00001 is statistically significant.

RESULTS

Total number of on pump CABG patients was 323 (90%) and off pump CABG was 29 (8%). Other case distribution is shown in Table-I. The intra-aortic balloon pump insertion was in 14 (3.9%) shown in Table-II. IABP was inserted in 6 (43%) female and 8 (57%) male patients. The highest incidence of IABP insertion was significant in patients with moderately reduced left ventricular EF as the P-value is 0.00000 and we have found the same frequency in the severely reduced EF patients. Patients having normal EF and having no need of IABP insertion were compared to moderate and severely reduced EF patients and the results are shown in (Table-III). All the patients who required IABP had previous history of myocardial infarction and it is a very significant factor requiring use of IABP. The use of IABP was more in hypertensive and diabetic patients such as 86% and 64% respectively. Frequency of IABP in Coronary artery endarterectomy is also not significant as P-value is 0.000395. The frequency was much less in smokers which is not significant as P-value is 0.022698 and it was almost same in diabetics, MI and Hypertensive patients as shown in Table-IV.

Table-I Number and percentage of CABG procedures.

Procedure	Number of cases	Percentages	
Total number of CABG	360	100%	
On Pump CABG	323	90%	
Off Pump CABG	29	8%	
Redo CABG	2	0.5%	
CABG plus Aortic valve replacement	4	1%	
CABG plus mitral valve replacement	2	0.5%	

Table-II Incidence of insertion of intra-aortic balloon pump (IABP).

IABP	Number	Percentage	
Total	360	100%	
Inserted	14	3.9%	
Not inserted	346	96.1 %	

Table-III Frequency of IABP insertion in terms of Ejection Fraction (EF).

Ejection fraction (EF) %	IABP inserted	
	
Number	Percentage	P value	
Normal EF>50%	4	28.6%	0.00000	
Moderately reduced EF 35-50%	6	42.8%	
Severely reduced EF<35%	4	28.6%	
Total	14	100%	

Table-IV Frequency of IABP insertion on the basis of other most common factors.

Factors	Total number	Percentage	P value	
Diabetes mellitus	9	64%	0.00000	
Hypertension	12	86%	0.00000	
Smoker	1	7%	0.022698	
Coronary endarterectomy	3	21%	0.000395	
Previous myocardial infarction (MI)	14	100%	0.00000	

DISCUSSION

Although surgical intervention is successful in patients with severe coronary artery disease yet, increasing benefits coupled with elevated threat, particularly for older patients with comorbidities like hypertension, diabetes mellitus, chronic obstructive pulmonary disease etc. remain a cause for concern. As a consequence, every contributory factor should be considered and wide-ranging scientific management should be practiced, including improving all system monitoring, cardio respiratory support and IABP incorporation.13

The foremost outcomes of IABP insertion are reduction of ventricular after load, enhancement coronary perfusion during diastole and augmentation of subendocardial blood flow resulting in elevated cardiac output and upgraded circulatory outcome. For these reasons, it is highly useful for patients with CABG14 regardless of the documented issues associated with IABP such as hemorrhage, vascular damage and platelet dysfunction. It is extensively used in modern era. So as to reduce intra hospital death rate which is as high as 26-50% among cardiac patients, use of IABP support is recommended.15 Use of IABP as an urgent measure for postoperative heart failure has time and again showed a survival rate of approximately 70% by many researchers. Another study has established an overall survival of 85% at four years for a cohort of patients who needed IABP supports post-operatively.16 Enhanced prognosis after cardiac surgery for coronary revascularization is dependent on preservation of cardiac system subsequent to cardiac operation. IABP has proved to be excellent treatment option for maintenance healthier cardiovascular system after cardiopulmonary bypass.17

One of the conditions after coronary artery bypass is stunned myocardium which is brief left ventricular dysfunction due to ischemic event to the heart muscle; IABP has an exceptional benefit in the recovery of this condition.18 In literature frequency of IABP application is mentioned 7 %16 and in some other studies it is 17% and 22%.19 It was reported 11.1% in the recently conducted local study.20

The use of IABP insertion of 3.9 % in our study is far less than the figures reported in literature and we expect that it may be just because of small study. Average age of patients who were subjected to IABP insertion in our study was 59.8 years with SD ± 1.26 as compared to scientific literature, use of IABP is generally applied in older age CABG patients and it is also similar to the local research 58.01 ±9.126.20,21

Incidence of hypertension was 86% in our research which is almost similar to reported studies.22 Another local study has also reported the higher number of hypertensive patients in IABP group.20 The other coexisting disease in this cohort of patients was diabetes that was 64% which is also very high and is reported 41.1% in other study.23 Elevated incidence of IABP use in diabetics might be due to the fact that these patients not only have larger scale of preexisting atherosclerosis but also elevated frequency of restenosis which leads to a higher percentage of myocardium unguarded and poorly re-vascularized so a larger percentage of the myocardium becomes ischemic.24

Incidence of previous myocardial infarction in our study was 100% in participants requiring IABP. This is comparable to the reported incidence in another study.25 It is still controversial as in another study recently it was reported 14.8%. We noticed in our research enhanced hemodynamic stability after initiation of IABP in patients with previous myocardial infarction making it very beneficial to use IABP in such patients.

We noticed in our research that incidence of IABP use was more in patient with moderately impaired left ventricle and it is reported 39.9% in other study. We reported the same frequency in both normal and severely reduced left ventricular fraction patients which is contrary to other studies which show less incidence of IABP in normal EF patients. These findings are somewhat controversial to those reported by Shah SMA, et al.20 showing higher incidence of IABP use in moderately reduced or severely reduced ejection fraction and was reduced in normal or good left ventricular function.

Our study further showed that incidence of IABP application does not increase with decreasing ejection fraction rather a good percentage of patients with normal ejection fraction required IABP which is contrary to what is reported.26 This is due to the fact that ejection fractions mentioned in echocardiography sometimes does not match with the actual ejection fraction of patients. We reported the mortality rate 35.7% which is comparable with those reported in the literature.27 Local study by Shah SMA, et al.20 has reported the mortality rate of 4.3%.

This higher mortality rate does not indicate that it was related IABP but it was due to critical condition and coexisting diseases in this group of patients. In other words IABP benefited 64% of critically ill patients. Mortality rate was 1.44% in patients without IABP. However, ICU stay and ventilator time was prolonged in IABP group which is similar to the findings of He XY.25

The scientific importance of our research is that application of IABP at any time during surgical intervention in patients with coronary artery disease having left ventricular dysfunction produces improved results due to on time support to myocardium and other vital organs prior to irreparable injury.

Limitation of the study

This study is based on small sample and it was performed to know only the incidence of IABP insertion in CABG patients during and after weaning from cardiopulmonary bypass and reported with few factors associated with IAPB use. Another study with larger sample size can be conducted with more variables among different groups for comparison and statistical significance.

CONCLUSION

IABP was mostly used in moderately reduced EF patients but also used in patients with good ventricular function when needed in CABG surgery with considerably excellent results. It is lifesaving mechanical support. In our study, IABP use was also considered in patients with recent MI, hypertensive and diabetic patients.

Authors' Contribution:

IA and MUR: Conceived, designed, did statistical analysis. manuscript writing and are responsible for integrity of the study.

MUI: Did data collection and editing of manuscript.

BK: Did review and final approval of manuscript.

Acknowledgements

The authors would like to thank Prof. Niaz Ali Khan and Dr. Niamat Ullah for their valuable suggestions regarding this study.

Conflicts of interest: None.

Grant support & financial disclosures: None.
==== Refs
REFERENCES

1 Virani SS Alonso A Benjamin EJ Bittencourt MS Callaway CW Carson AP Heart disease and stroke statistics—2020 update:a report from the American Heart Association Circulation 2020 141 9 E139 596 doi:10.1161/CIR.0000000000000757 31992061
2 Wysocka A Cybulski M Berbec H Wysokinski A Stazka J Zapolski T Prognostic value of paraoxonase 1 in patients undergoing coronary artery bypass grafting surgery Med Sci Monit 2014 20 594 doi:10.12659/MSM.890025 24721823
3 Gurses E Berk D Sungurtekin H Mete A Serin S Effects of high thoracic epidural anesthesia on mixed venous oxygen saturation in coronary artery bypass grafting surgery Med Sci Monit 2013 19 222 doi:10.12659/MSM.883861 23531633
4 Gogbashian A Sedrakyan A Treasure T EuroSCORE:a systematic review of international performance Eur J Cardiothorac Surg 2004 25 5 695 700 doi:10.1016/j.ejcts.2004.02.022 15082269
5 Lichtman JH Froelicher ES Blumenthal JA Carney RM Doering LV Frasure-Smith N Depression as a risk factor for poor prognosis among patients with acute coronary syndrome:systematic review and recommendations:a scientific statement from the American Heart Association Circulation 2014 373-39-5644 1369 doi:10.1161/CIR.0000000000000019 24566200
6 Velazquez EJ Lee KL Deja MA Jain A Sopko G Marchenko A Coronary-artery bypass surgery in patients with left ventricular dysfunction N Engl J Med 2011 373-39-5644 1616 doi:10.1056/NEJMoa1100356 21463150
7 Authors/Task Force Members Kolh P Windecker S Alfonso F Collet JP Cremer J 2014 ESC/EACTS guidelines on myocardial revascularization:The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur J Cardiothorac Surg 2014 46 4 517 592 doi:10.1093/ejcts/ezu366 25173601
8 Lomivorotov VV Efremov SM Kirov MY Fominskiy EV Karaskov AM Low-cardiac-output syndrome after cardiac surgery Semin Cardiothorac Vasc Anesth 2017 31 1 291 308 doi:10.1053/j.jvca.2016.05.029
9 Werdan K Gielen S Ebelt H Hochman JS Mechanical circulatory support in cardiogenic shock Eur Heart J 2014 35 3 156 167 doi:10.1093/eurheartj/eht248 24014384
10 Nakamura K Hamasaki A Uchida T Kobayashi K Sho R Kim C The use of prophylactic intra-aortic balloon pump in high-risk patients undergoing coronary artery bypass grafting PloS One 2019 14 10 e0224273 doi:10.1371/journal.pone.0224273 31658283
11 Freitas AC Gurian DB Saporito WF Machado LN Horiuti L Pires AC Preoperative Intra-Aortic Balloon Counterpulsation in Coronary Artery Bypass Graft Patients with Severe Left Ventricular Dysfunction World J Cardiovasc Dis +1-587-573-2526 doi:10.4236/wjcd.+1-587-573-2526
12 Khan TM Siddiqui AH Intra-Aortic Balloon Pump (IABP) StatPearls [Internet] 2020 https://www.ncbi.nlm.nih.gov/books/NBK542233/. (Google scholar)
13 Zhang J Lang Y Guo L Song X Shu L Su G Preventive use of intra-aortic balloon pump in patients undergoing high-risk coronary artery bypass grafting:a retrospective study Medical Science Monitor:Med Sci Monit 2015 21 855 doi:10.12659/MSM.893021 25797193
14 Yumun G Aydin U Ata Y Toktaş F Pala AA Ozyazicioglu AF Turk T Yavuz S Analysis of clinical outcomes of intra-aortic balloon pump during coronary artery bypass surgery Cardiovasc J Afr 2015 26 3 130 26925473
15 Gilotra NA Stevens GR Temporary mechanical circulatory support:a review of the options indications, and outcomes Clinical Medicine Insights:Cardiology 2014 8 CMC S15718 doi:10.4137/CMC.S15718
16 Parissis H Graham V Lampridis S Lau M Hooks G Mhandu PC IABP:history-evolution-pathophysiology-indications:what we need to know J Thorac Cardiovasc Surg 2016 11 1 1 3 doi:10.1186/s13019-016-0513-0
17 Parissis H Leotsinidis M Akbar MT Apostolakis E Dougenis D The need for intra aortic balloon pump support following open heart surgery:risk analysis and outcome J Thorac Cardiovasc Surg 2010 5 1 20
18 Phillips HR O'Connor CM Rogers J Revascularization for heart failure Am Heart J 2007 153 4 65 73 doi:10.1016/j.ahj.2007.01.026 17394905
19 Jannati M Attar A Intra-aortic balloon pump postcardiac surgery:A literature review J Res Med Sci 2019 24 6 doi:10.4103/jrms.JRMS 373-39-56445019
20 Shah SMA Awan NI Jan A Rehman MU The Characteristics, morbidity and mortality factors associated with Intra-Aortic Balloon Pump in Coronary Artery Bypass Graft Surgery patients Pak J Med Sci 2020 36 6 1318 1324 doi:10.12669/pjms.36.6.2649 32968401
21 Wiegmann B Ismail I Haverich A Herzchirurgie im Alter (Cardiac surgery in the elderly) Wien Klin Wochenschr 2017 20 3 76 81 doi:10.1007/s00740-017-0172-3
22 Ercan A Gurbuz O Ercan A Tuydeş O Bicer M Saba D Vascular complications of intra-aortic balloon pump usage in coronary bypass surgery:18 years of experience J Pak Med Assoc 2014 64 1 28 32 24605709
23 Aronson D Edelman ER Coronary artery disease and diabetes mellitus Cardiol Clin 2014 32 3 439 455 doi:10.1016/j.ccl.2014.04.001 25091969
24 Schmidt AM Diabetes mellitus and cardiovascular disease:emerging therapeutic approaches Arterioscler Thromb Vasc Biol 2019 39 4 558 568 doi:10.1161/ATVBAHA.119.310961 30786741
25 He XY Gao CQ Peri-operative application of intra-aortic balloon pumping reduced in-hospital mortality of patients with coronary artery disease and left ventricular dysfunction Chin Med J (Engl) 2019 132 8 935 doi:10.1097/CM9.0000000000000178 30958435
26 Moulopoulos SD Intra-aortic balloon counterpulsation 50 years later:initial conception and consequent ideas Artif Organs 2011 35 9 843 848 doi:10.1111/j.1525-1594.2011.01284.x 21752036
27 Oliveira TM Oliveira GM Klein CH Souza e Silva NA Godoy PH Mortality and complications of coronary artery bypass grafting in Rio de Janeiro, from 1999 to 2003 Arq Bras Cardiol 2010 95 3 303 312 doi:10.1590/S0066-782X2010005000091 20640383


{'source': 'PubMedDataset'}